Synlogic, Inc. (NASDAQ:SYBX – Get Free Report) passed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $1.17 and traded as low as $1.07. Synlogic shares last traded at $1.07, with a volume of 2,382 shares trading hands.
Synlogic Trading Down 3.8%
The company has a market capitalization of $12.49 million, a PE ratio of -3.92 and a beta of 0.61. The firm has a 50 day simple moving average of $1.17 and a two-hundred day simple moving average of $0.87.
Synlogic Company Profile
Synlogic, Inc was a clinical-stage biotechnology company focused on developing medicines based on synthetic biology. The company engineered probiotic bacteria, referred to as Synthetic Biotics, to perform specific therapeutic functions inside the gastrointestinal tract, such as metabolizing disease-associated compounds or producing beneficial molecules.
Its development programs targeted rare metabolic disorders, including phenylketonuria (PKU) and homocystinuria. Among its investigational candidates were SYNB1934 and the earlier SYNB1618 for PKU, as well as SYNB1353 for homocystinuria.
Further Reading
- Five stocks we like better than Synlogic
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Synlogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synlogic and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}